Lincoln National has climbed 11% in a week, Q2 earnings are three weeks away, and the executives who sold in late May and early June got out at lower prices than where the stock trades today.
The insider picture is the most telling detail in this week's snapshot. Between May 22 and June 5, five senior LNC executives — including the Chief Risk Officer, the HR Director, and two Executive Vice Presidents — collectively sold more than 176,000 shares worth roughly $5.3 million. Those transactions cleared at prices ranging from $34.45 to $36.03. The stock closed Tuesday at $39.19, meaning the sellers left real money on the table. Net insider activity over the 90-day window runs to around 184,500 shares and approximately $6.5 million in net value, almost entirely composed of those sales. The only buy on record in the window was a $9,783 purchase by the Chief Information Officer in March — a rounding error by comparison.
Short positioning tells a calmer story. SI runs at roughly 5.1% of the free float — meaningful but not extreme. The week's 1.5% increase in shares short is modest and shows no sign of a directional bet building ahead of the July 30 print. More telling is the lending market: availability is running near 1,188% of short interest, which means there are roughly twelve lendable shares for every one currently borrowed. Borrowing costs at 0.59% are up 31% on the week, but from an exceptionally low base, and the absolute rate remains trivial. Nothing in the borrow market suggests short sellers are under pressure or that a squeeze dynamic is forming. The ORTEX short score of 46 — stable and mid-range — confirms the positioning is neither aggressive nor retreating.
Options traders have shifted away from the defensive posture that dominated through May and early June. The put/call ratio at 0.97 is now more than one standard deviation below its 20-day average of 1.08, and the drift lower has been consistent since early June when the ratio was running above 1.22. That rotation away from downside protection aligns with the stock's 13% one-month gain and suggests hedgers have been unwinding rather than adding cover into the rally. The 52-week high for the PCR was 1.53 — where the stock sat at a very different valuation. Today's reading looks comparatively bullish, or at least less frightened.
The Street has turned modestly more constructive this week. Barclays upgraded LNC to Overweight on Monday, lifting its target from $42 to $45. UBS moved the same day, raising its target from $39 to $44 while staying Neutral. The mean price target across the analyst panel lands at $43.25 — about 10% above current levels, which is tighter than it looked a few weeks ago after the rally. The bull case centres on the Bain Capital strategic investment, LNC's pivot toward spread-based products like registered index-linked annuities, and strong Group Protection utilisation rates. Bears point to net investment income headwinds, persistent outflows in the Annuities and Retirement segments, and the structural complexity of the legacy liability book. Valuation on a trailing P/E near 4.6x and price-to-book below 0.7x keeps LNC optically cheap, though the ORTEX factor scores flag weak EPS momentum — 14th percentile over 90 days, 24th over 30 days — as a reason for caution on the growth narrative. Bain Capital holds 9.8% of shares; BlackRock has been adding modestly, reported at 9.7% as of June 30.
Earnings on July 30 will be the next forcing function. The three most recent post-results sessions have each produced negative one-day moves — the worst was a 4.8% drop — with five-day losses extending further in two of those three cases. Whether the stock can hold its recent gains depends largely on whether LNC delivers progress on the investment income line and stemming the annuity outflows that have dogged recent quarters.
See the live data behind this article on ORTEX.
Open LNC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.